MedTrace Logo

Symbicort Onset of Action 1

NCT00646620 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2009-04-06

No results posted yet for this study

Summary

The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma

Conditions

Interventions

DRUG

budesonide/formoterol (Symbicort)

DRUG

fluticasone/salmeterol (Advair Diskus)

DRUG

albuterol (Ventolin)

Sponsors & Collaborators

Principal Investigators

  • Catherine Bonuccelli · AstraZeneca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2003-09-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00646620 on ClinicalTrials.gov